Capoten and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Capoten (captopril), especially for people who are male, 60+ old, also take Lasix, and have Cardiac failure congestive.

The phase IV clinical study analyzes which people have Nosebleed when taking Capoten. It is created by eHealthMe based on reports of 2,931 people who have side effects when taking Capoten from the FDA, and is updated regularly.

What is Capoten?

Capoten has active ingredients of captopril. It is often used in high blood pressure. eHealthMe is studying from 2,954 Capoten users. Check the latest studies of Capoten.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,080 drugs and 3,093 conditions by eHealthMe. Check the latest studies of Nosebleed.

On Jul, 17, 2026

2,931 people reported to have side effects when taking Capoten.
Among them, 18 people (0.61%) have Nosebleed.

Among these 18 people:

What is the gender of people who have Nosebleed when taking Capoten? *

female: 50 %
male: 50 %

What is the age of people who have Nosebleed when taking Capoten? *

What are other drugs people take besides Capoten? *

What are other side effects people have besides Nosebleed? *

Chest Pain: 6 people, 33.33%
Hypotension (abnormally low blood pressure): 6 people, 33.33%
Dyspnea (difficult or laboured breathing): 5 people, 27.78%
Dizziness: 5 people, 27.78%
Cardiac Failure Congestive: 5 people, 27.78%
Weakness: 4 people, 22.22%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 4 people, 22.22%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 22.22%
Mood Swings (an extreme or rapid change in mood): 4 people, 22.22%
Fatigue (feeling of tiredness): 3 people, 16.67%

What are the existing conditions these people have? *

Cardiac Failure Congestive: 2 people, 11.11%
Type 2 Diabetes: 1 person, 5.56%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 5.56%
Pain In Extremity: 1 person, 5.56%
Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 5.56%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 1 person, 5.56%
Heart Attack: 1 person, 5.56%
Diabetes: 1 person, 5.56%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 5.56%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Capoten and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Capoten:

Capoten (2,954 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

Browse all side effects of Capoten:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,080 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,093 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on captopril (the active ingredients of Capoten) and Capoten (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.